<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>18452216</Do_id>
  <Journal>Journal of surgical oncology</Journal>
  <Doc_title>Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors.</Doc_title>
  <Doc_abstract>None</Doc_abstract>
  <Doc_ChemicalList>Antineoplastic Agents;Benzamides;Piperazines;Pyrimidines;Imatinib Mesylate;Protein-Tyrosine Kinases</Doc_ChemicalList>
  <Doc_meshdescriptors>Antineoplastic Agents;Benzamides;Chemotherapy, Adjuvant;Gastrointestinal Stromal Tumors;Humans;Imatinib Mesylate;Neoplasm Staging;Piperazines;Protein-Tyrosine Kinases;Pyrimidines</Doc_meshdescriptors>
  <Doc_meshqualifiers>therapeutic use;drug therapy;pathology;therapeutic use;antagonists &amp; inhibitors;therapeutic use</Doc_meshqualifiers>
</Document>
